A primary focus of LEV Foundation’s work is to empirically demonstrate the feasibility and value of the divide-and-conquer approach to treating age-related disease – that is, the simultaneous deployment of therapies that independently address the distinct classes of damage that accumulate in aging bodies. With a steadily increasing number of such therapies now showing benefits ... Read more
There are various approvals that will start in Netherlands in April 2025, there will be a EU vote in May 2025 and then the various countries in the EU will approve Tesla FSD from Jun-October 2025.